Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-24T17:50:45.548Z Has data issue: false hasContentIssue false
  • English
  • Français

Biomarkers intersection between depression, diabetes, and cognitive impairment

Published online by Cambridge University Press:  03 February 2020

Breno S. Diniz
Breno S. Diniz*
Affiliation:
Assistant Professor, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada Clinician Scientist, Adult Neurodevelopment and Geriatric Psychiatry Division and The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
*
Email: Breno.Diniz@camh.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 32 , Issue 1: Issue Theme: Cultural Diversity in Psychogeriatrics , January 2020 , pp. 5 - 6
Copyright
© International Psychogeriatric Association 2020 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Castro-Costa, E. et al. (2019). Diabetes, depressive symptoms, and mortality risk in old age: the role of inflammation. Depress Anxiety, 36, 941–949.10.1002/da.22908CrossRefGoogle ScholarPubMed
Diniz, B. S. et al. (2010). Increased soluble tnf receptor 2 in antidepressant-free patients with late-life depression. Journal of Psychiatry Research, 44, 917–920.CrossRefGoogle ScholarPubMed
Diniz, B. S. et al. (2011). Platelet gsk3b activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? World Journal of Biological Psychiatry, 12, 216–222.10.3109/15622975.2010.551408CrossRefGoogle ScholarPubMed
Diniz, B. S. et al. (2016). Circulating biosignatures of late-life depression (lld): towards a comprehensive, data-driven approach to understanding lld pathophysiology. Journal of Psychiatric Research, 82, 1–7.10.1016/j.jpsychires.2016.07.006CrossRefGoogle ScholarPubMed
Diniz, B. S., Fisher-Hoch, S. and McCormick, J. (2018). The association between insulin resistance, metabolic variables, and depressive symptoms in mexican-american elderly: a population-based study. International Journal of Geriatric Psychiatry, 33, e294–e299.10.1002/gps.4792CrossRefGoogle ScholarPubMed
Johnson, L. A. et al. (2019). The impact of comorbid depression – diabetes on proteomic outcomes among community-dwelling Mexican Americans with mild cognitive impairment. International Psychogeriatrics, 32, 17–23. doi: 10.1017/S1041610219001625CrossRefGoogle Scholar
Katon, W. et al. (2015). Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry, 72, 612–619.10.1001/jamapsychiatry.2015.0082CrossRefGoogle ScholarPubMed
Smagula, S. F. et al. (2016). Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder. Journal of Psychiatric Research, 81, 112–118.CrossRefGoogle ScholarPubMed